Many believe Medicare and private payers frequently deny coverage for secondary imaging interpretations—but a team of East Coast researchers found the opposite in a study analyzing Medicare beneficiaries from 2003 to 2016.

The largest U.S. health insurers aren’t likely to be at risk of negative credit ratings after the Trump administration halted about $10 billion in risk adjustment payments, according to Fitch Ratings.

Failure-to-communicate lawsuits are on the rise among radiologists, according to an editorial published in the Journal of the American College of Radiology this month, leaving legal lines of the specialization blurry.

After work requirements for eligible Medicaid beneficiaries too effect in Arkansas, more than 7,000 people failed to report they worked at least 80 hours in June.

U.S. antitrust enforcers might not move to block CVS Health’s acquisition of health insurance company Aetna, Bloomberg reported.

The FDA has issued a voluntary recall of valsartan, due to concerns of an impurity N-nitrosodimethylamine (NDMA), a known carcinogen, which was found in a batch of the drug manufactured in China. Valsartan is commonly used to control hypertension and heart failure.

The National Electrical Manufacturers Association (NEMA) published its updated guidelines for measuring and reporting performance specifications of PET scanners on Friday, July 13.

Federal investigators say former HHS Secretary Tom Price wasted $341,000 of taxpayer money for his use of chartered jets and military aircraft, The New York Times reported Friday.